Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Taubert

Showing results (51-60 of 120) with videos related to

Pageof 12
Sort By:
Cancer Research|July 19, 2005
Expression of a natural tumor antigen by thymic epithelial cells impairs the tumor-protective CD4+ T-cell repertoireRinke Bos, Suzanne van Duikeren, Thorbald van Hall, et al.
European Journal of Gastroenterology & Hepatology|March 29, 2017
Home-based drainage of refractory ascites by a permanent-tunneled peritoneal catheter can safely replace large-volume paracentesisPhilipp Solbach, Christoph Höner Zu Siederdissen, Richard Taubert, et al.
Journal of Hepatology|June 3, 2014
Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapiesRichard Taubert, Matthias Hardtke-Wolenski, Fatih Noyan, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 2, 2016
Preferential accumulation of T helper cells but not cytotoxic T cells characterizes benign subclinical rejection of human liver allograftsAnna K Baumann, Jerome Schlue, Fatih Noyan, et al.
Scientific Reports|November 30, 2018
Increased seroprevalence of HAV and parvovirus B19 in children and of HEV in adults at diagnosis of autoimmune hepatitisRichard Taubert, Jana Diestelhorst, Norman Junge, et al.
Journal of Clinical Medicine|December 24, 2021
Adjuvant Therapy with Budesonide Post-Kasai Reduces the Need for Liver Transplantation in Biliary AtresiaJoachim F Kuebler, Omid Madadi-Sanjani, Eva D Pfister, et al.
Journal of Autoimmunity|April 23, 2024
Blockade of neutrophil extracellular trap components ameliorates cholestatic liver disease in Mdr2 (Abcb4) knockout miceEdith Hintermann, Camilla Tondello, Sina Fuchs, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 24, 2024
<i>In Vitro</i> Profiling of Commonly Used Post-transplant Immunosuppressants Reveals Distinct Impact on Antiviral T-cell Immunity Towards CMVMarkus Benedikt Krueger, Agnes Bonifacius, Anna Christina Dragon, et al.
Hepatology (Baltimore, Md.)|March 12, 2013
Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cellsMatthias Hardtke-Wolenski, Katja Fischer, Fatih Noyan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 29, 2021
Outcome and safety of a surveillance biopsy guided personalized immunosuppression program after liver transplantationEmily A Saunders, Bastian Engel, Anne Höfer, et al.
Pageof 12

Showing results (51-60 of 120) with videos related to

Sort By:
Pageof 12
Cancer Research|July 19, 2005
Expression of a natural tumor antigen by thymic epithelial cells impairs the tumor-protective CD4+ T-cell repertoireRinke Bos, Suzanne van Duikeren, Thorbald van Hall, et al.
European Journal of Gastroenterology & Hepatology|March 29, 2017
Home-based drainage of refractory ascites by a permanent-tunneled peritoneal catheter can safely replace large-volume paracentesisPhilipp Solbach, Christoph Höner Zu Siederdissen, Richard Taubert, et al.
Journal of Hepatology|June 3, 2014
Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapiesRichard Taubert, Matthias Hardtke-Wolenski, Fatih Noyan, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 2, 2016
Preferential accumulation of T helper cells but not cytotoxic T cells characterizes benign subclinical rejection of human liver allograftsAnna K Baumann, Jerome Schlue, Fatih Noyan, et al.
Scientific Reports|November 30, 2018
Increased seroprevalence of HAV and parvovirus B19 in children and of HEV in adults at diagnosis of autoimmune hepatitisRichard Taubert, Jana Diestelhorst, Norman Junge, et al.
Journal of Clinical Medicine|December 24, 2021
Adjuvant Therapy with Budesonide Post-Kasai Reduces the Need for Liver Transplantation in Biliary AtresiaJoachim F Kuebler, Omid Madadi-Sanjani, Eva D Pfister, et al.
Journal of Autoimmunity|April 23, 2024
Blockade of neutrophil extracellular trap components ameliorates cholestatic liver disease in Mdr2 (Abcb4) knockout miceEdith Hintermann, Camilla Tondello, Sina Fuchs, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 24, 2024
<i>In Vitro</i> Profiling of Commonly Used Post-transplant Immunosuppressants Reveals Distinct Impact on Antiviral T-cell Immunity Towards CMVMarkus Benedikt Krueger, Agnes Bonifacius, Anna Christina Dragon, et al.
Hepatology (Baltimore, Md.)|March 12, 2013
Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cellsMatthias Hardtke-Wolenski, Katja Fischer, Fatih Noyan, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 29, 2021
Outcome and safety of a surveillance biopsy guided personalized immunosuppression program after liver transplantationEmily A Saunders, Bastian Engel, Anne Höfer, et al.
Pageof 12